Bentham Science Logo

Track Your Manuscript:

Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access


Current Cancer Drug Targets, Volume 14 - Number 6

Deubiquitinating Enzyme Inhibitors and their Potential in Cancer Therapy

, 14(6): 506 - 516

Bernat Crosas

DOI: 10.2174/1568009614666140725090620

Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System

, 14(6): 517 - 536

Q. Ping Dou and Jeffrey A. Zonder

DOI: 10.2174/1568009614666140804154511

The Immunoproteasome as a Therapeutic Target for Hematological Malignancies

, 14(6): 537 - 548

Zachary Miller, Wooin Lee and Kyung Bo Kim

DOI: 10.2174/1568009614666140723113139

NEDD4: A Promising Target for Cancer Therapy

, 14(6): 549 - 556

Xiantao Ye, Lixia Wang, Bingxue Shang, Zhiwei Wang and Wenyi Wei

DOI: 10.2174/1568009614666140725092430

Arsenic Trioxide Exerts Anti-lung Cancer Activity by Inhibiting Angiogenesis

, 14(6): 557 - 566

Meng-Hang Yang, Yuan-Sheng Zang, Hai Huang, Kun Chen, Bing Li, Guang-Yuan Sun and Xue-Wei Zhao

DOI: 10.2174/1568009614666140725090000

Structure, Function, and Pathogenesis of SHP2 in Developmental Disorders and Tumorigenesis

, 14(6): 567 - 588

Wen-Qing Huang, Qing Lin, Xuan Zhuang, Liang-Liang Cai, Run-Sheng Ruan, Zhong-Xian Lu and Chi-Meng Tzeng

DOI: 10.2174/1568009614666140717105001


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.



Related Journals

Related eBooks

eBooks Catalog